MODELING THE DYNAMICS OF CHRONIC MYELOGENOUS LEUKEMIA THROUGH FRACTIONAL-CALCULUS

被引:0
|
作者
Tang, Tao-Qian [1 ,2 ,3 ,4 ,5 ]
Jan, Rashid [6 ]
Rehman, Ziad Ur [6 ]
Shah, Zahir [7 ]
Vrinceanu, Narcisa [8 ]
Racheriu, Mihaela [9 ,10 ]
机构
[1] Natl Tsing Hua Univ, Int Intercollegiate PhD Program, Hsinchu 30013, Taiwan
[2] E DA Hosp, Dept Internal Med, Kaohsiung 82445, Taiwan
[3] I Shou Univ, Sch Med, Coll Med, Kaohsiung 82445, Taiwan
[4] E DA Hosp, Dept Family & Community Med, Kaohsiung 82445, Taiwan
[5] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan
[6] Univ Swabi, Dept Math, Swabi 23430, Khyber Pakhtunk, Pakistan
[7] Univ Lakki Marwat, Dept Math Sci, Lakki Marwat 28420, Khyber Pakhtunk, Pakistan
[8] Lucian Blaga Univ Sibiu, Fac Engn, Dept Ind Machines & Equipment, 10 Victoriei Blvd, Sibiu 550024, Romania
[9] Lucian Blaga Univ Sibiu, Fac Med, Str 2A Lucian Blaga, Sibiu 550169, Romania
[10] Cty Clin Emergency Hosp, 2-4 Corneliu Coposu Str, Sibiu 550245, Romania
关键词
Chronic Myelogenous Leukemia (CML); Fractional Dynamics; Stability Results; Immune System; Numerical Analysis; Dynamical Behavior; CHRONIC MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; IMATINIB; INTERFERON; MULTICENTER; STABILITY; ALPHA;
D O I
10.1142/S0218348X22402629
中图分类号
O1 [数学];
学科分类号
0701 ; 070101 ;
摘要
Although the therapy of chronic myelogenous leukemia (CML) has progressed because of imatinib (IM) and other tyrosine kinase inhibitors (TKIs), the majority of patients still do not recover. To better regulate the remaining leukemic cell population, TKI combo therapy may be improved with a deeper understanding of the underlying mechanisms. We employed a mathematical system which incorporated the intricate phenomena of immune system to CML. We use a fractional derivative framework in this work to understand the dynamics of CML. Additionally, in our work, we concentrate on the qualitative characterization and dynamical behavior of CML interactions. For the proposed model, we examine the singularity and existence using fixed point theorems by Banach and Schaefer. We provide the necessary criteria for our suggested fractional model's Ulam-Hyers stability. The influence of the factors on the dynamics of CML is highlighted by closely examining the solution paths by using a numerical scheme. To be more precise, we emphasized how the suggested system's dynamic and chaotic behavior varied depending on the fractional order and other system factors. Policymakers are advised to consider the most crucial elements of CML dynamics. In order to inform policymakers and health authorities about the systems essential for control and treatment, it is crucial to investigate the dynamic characteristics of CML disease.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Fractional-calculus model for temperature and pressure waves in fluid-saturated porous rocks
    Garra, Roberto
    [J]. PHYSICAL REVIEW E, 2011, 84 (03):
  • [42] Series representations for fractional-calculus operators involving generalised Mittag-Leffler functions
    Fernandez, Arran
    Baleanu, Dumitru
    Srivastava, H. M.
    [J]. COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION, 2019, 67 : 517 - 527
  • [43] Some fractional-calculus results involving the generalized Lommel-Wright and related functions
    Prieto, Ana Isolina
    de Romero, Susana Salinas
    Srivastava, H. M.
    [J]. APPLIED MATHEMATICS LETTERS, 2007, 20 (01) : 17 - 22
  • [44] A naturally emerging bivariate Mittag-Leffler function and associated fractional-calculus operators
    Fernandez, Arran
    Kurt, Cemaliye
    Ozarslan, Mehmet Ali
    [J]. COMPUTATIONAL & APPLIED MATHEMATICS, 2020, 39 (03):
  • [45] Modeling the dynamics of tumor–immune cells interactions via fractional calculus
    Tao-Qian Tang
    Zahir Shah
    Rashid Jan
    Ebraheem Alzahrani
    [J]. The European Physical Journal Plus, 137
  • [46] Hypomethylation dynamics following decitabine therapy in chronic myelogenous leukemia.
    Issa, JPJ
    Gharibyan, V
    Jelinek, J
    Morris, G
    Verstovsek, S
    Talpaz, M
    Garcia-Manero, G
    Kantarjian, HM
    [J]. BLOOD, 2004, 104 (11) : 808A - 808A
  • [47] Post-transplantation dynamics of the immune response to chronic myelogenous leukemia
    DeConde, R
    Kim, PS
    Levy, D
    Lee, PP
    [J]. JOURNAL OF THEORETICAL BIOLOGY, 2005, 236 (01) : 39 - 59
  • [48] Infliximab in chronic myelogenous leukemia
    Mittre, Herve
    Marcelli, Christian
    Leporrier, Michel
    [J]. LEUKEMIA RESEARCH, 2007, 31 (03) : 418 - 419
  • [49] JUVENILE CHRONIC MYELOGENOUS LEUKEMIA
    FREEDMAN, MH
    ESTROV, Z
    CHAN, HSL
    [J]. AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1988, 10 (03): : 261 - 267
  • [50] Chronic Myelogenous Leukemia in Childhood
    Stephanie M. Smith
    Nobuko Hijiya
    Kathleen M. Sakamoto
    [J]. Current Oncology Reports, 2021, 23